![WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer | Cell Death & Disease WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-020-03210-5/MediaObjects/41419_2020_3210_Fig1_HTML.png)
WDHD1 is essential for the survival of PTEN-inactive triple-negative breast cancer | Cell Death & Disease
![Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer - Urology Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer - Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8a069bf7-45b2-422a-a707-f0e8bbe0d2b6/url20772-fig-0001_lrg.jpg)
Clinical Utility and Biologic Implications of Phosphatase and Tensin Homolog (PTEN) and ETS-related Gene (ERG) in Prostate Cancer - Urology
![Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer | Cancer Genomics & Proteomics Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer | Cancer Genomics & Proteomics](https://cgp.iiarjournals.org/content/cgp/16/3/195/F1.large.jpg)
Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer | Cancer Genomics & Proteomics
![Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG) - European Journal of Cancer Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG) - European Journal of Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3f9bb3ee-8be3-4239-bd43-3ef0a16999fc/gr1.jpg)
Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: Results from studies of the NCIC Clinical Trials Group (NCIC CTG) - European Journal of Cancer
Rare Diseases Clinical Research Network (RDCRN) - PTEN hamartoma tumor syndrome is a genetic condition in which non-cancerous growths, called hamartomas, develop in different areas of the body. The disease is hereditary,
![Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML](https://www.mdpi.com/cancers/cancers-11-01765/article_deploy/html/images/cancers-11-01765-g002.png)
Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML
![Participation of HSP27, PTEN, p53 and P-gp in drug resistance. HSF1 can... | Download Scientific Diagram Participation of HSP27, PTEN, p53 and P-gp in drug resistance. HSF1 can... | Download Scientific Diagram](https://www.researchgate.net/profile/Fernando-Cuello-Carrion/publication/288889229/figure/fig3/AS:356304599175170@1461961044990/Fig-3-Participation-of-HSP27-PTEN-p53-and-P-gp-in-drug-resistance-HSF1-can-induce.png)
Participation of HSP27, PTEN, p53 and P-gp in drug resistance. HSF1 can... | Download Scientific Diagram
![Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium | British Journal of Cancer Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-020-0900-0/MediaObjects/41416_2020_900_Fig1_HTML.png)
Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium | British Journal of Cancer
![Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers | Nature Communications Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-29227-2/MediaObjects/41467_2022_29227_Fig1_HTML.png)
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers | Nature Communications
![Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML](https://www.mdpi.com/cancers/cancers-11-01765/article_deploy/html/images/cancers-11-01765-g001.png)
Cancers | Free Full-Text | PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target | HTML
PLOS Medicine: Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
![65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine in: Endocrine-Related Cancer Volume 25 Issue 8 (2018) 65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine in: Endocrine-Related Cancer Volume 25 Issue 8 (2018)](https://erc.bioscientifica.com/view/journals/erc/25/8/images/ERC-18-0162fig5.jpeg)
65 YEARS OF THE DOUBLE HELIX: One gene, many endocrine and metabolic syndromes: PTEN-opathies and precision medicine in: Endocrine-Related Cancer Volume 25 Issue 8 (2018)
![Frontiers | The Role of PI3K Inhibition in the Treatment of Breast Cancer, Alone or Combined With Immune Checkpoint Inhibitors | Molecular Biosciences Frontiers | The Role of PI3K Inhibition in the Treatment of Breast Cancer, Alone or Combined With Immune Checkpoint Inhibitors | Molecular Biosciences](https://www.frontiersin.org/files/Articles/648663/fmolb-08-648663-HTML/image_m/fmolb-08-648663-g001.jpg)
Frontiers | The Role of PI3K Inhibition in the Treatment of Breast Cancer, Alone or Combined With Immune Checkpoint Inhibitors | Molecular Biosciences
![Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment? | Journal of Translational Medicine | Full Text Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment? | Journal of Translational Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12967-020-02219-w/MediaObjects/12967_2020_2219_Fig1_HTML.png)
Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment? | Journal of Translational Medicine | Full Text
![References in KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology References in KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c7e8c664-8508-450b-b3fc-6c4c3bf22724/gr1_lrg.jpg)
References in KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer - The Lancet Oncology
![Comprehensive PTEN Hamartoma Tumor Syndrome (PHTS) Multidisciplinary Clinic | Children's Hospital of Philadelphia Comprehensive PTEN Hamartoma Tumor Syndrome (PHTS) Multidisciplinary Clinic | Children's Hospital of Philadelphia](https://www.chop.edu/sites/default/files/parkway-ambassadors-dylan-780x439.jpg)
Comprehensive PTEN Hamartoma Tumor Syndrome (PHTS) Multidisciplinary Clinic | Children's Hospital of Philadelphia
![Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review Prognostic value of the PIK3CA, AKT, and PTEN mutations in oral squamous cell carcinoma: literature review](https://www.archivesofmedicalscience.com/f/fulltexts/91676/AMS-17-1-91676-g001.jpg)